INVESTIGADORES
ARROSSI Silvina Paula
congresos y reuniones científicas
Título:
PROGRAMMATIC INTRODUCTION OF HPV TESTING IN ARGENTINA: LESSONS AND CHALLENGES
Autor/es:
ARROSSI S
Lugar:
Santiago de Chile
Reunión:
Congreso; Primer Encuentro Sudamericano de VPH; 2014
Resumen:
In Argentina, in 2011, Argentina launched a Demonstration Project to introduce HPV testing as a primary screening tool, which was implemented in the Province of Jujuy, one of the provinces with highest cervical cancer mortality rates; it involved introducing HPV Testing in the public health system for women aged 30 and over, and triage with cytology for HPV+ women.   The project was led by the National Cancer Institute in collaboration with the National Program of Cervical Cancer Prevention In 2011 key activities were planned and implemented through a consensus process that involved main stakeholders and decision-makers. The screening phase began in 2012 and it is planned to take place during 2012-2014. The goal is to screen 22000 women annually during three years, to reach 80% coverage. Consensus to introduce HPV Testing was agreed with scientific societies, representatives from provincial ministries of health, and key opinion leaders. A HPV-laboratory was organized at Jujuy?s main hospital, as a laboratory depending of the Cytho-pathology Service. At present, of the 300 provincial health care centers, 100% is offering HPV testing to women aged 30 and over. During 2012, 22854 women were HPV-screened at the public health care system; 1,5% of them were younger than 30.  Among the 22515 women aged 30 and over who were screened, 12,7% tested HPV+, of whom 807 had an abnormal Pap smear. By December 31, 2013, 76% of HPV-positive women with an abnormal Pap have had colposcopies and biopsies if needed. Based on these diagnoses, detection rate of hystologically confirmed CIN2+ was 1,25% (281/22515).  Introduction of HPV testing in Argentina was successfully implemented, and based on these results, the Ministry of Health is expanding the strategy to all 24 provinces. This project demonstrates that HPV testing can be introduced at programmatic level in middle-low income countries.